ASP Isotopes Files 8-K on Sept 30, 2025

Ticker: ASPI · Form: 8-K · Filed: Sep 30, 2025 · CIK: 1921865

Sentiment: neutral

Topics: 8-K, disclosure, financials

TL;DR

ASP Isotopes filed an 8-K on 9/30/25. Check for Reg FD and financials.

AI Summary

ASP Isotopes Inc. filed an 8-K report on September 30, 2025, disclosing information related to Regulation FD and financial statements. The filing indicates the company's principal executive offices are located at 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, DC 20004.

Why It Matters

This 8-K filing provides official updates and disclosures from ASP Isotopes Inc. to the SEC, which are important for investors to monitor company activities and financial status.

Risk Assessment

Risk Level: low — This filing is a routine 8-K report and does not contain specific financial results or significant corporate events that would inherently increase risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by ASP Isotopes Inc.?

The 8-K filing is for a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, specifically covering Regulation FD Disclosure and Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The date of the earliest event reported is September 30, 2025.

What is the official address of ASP Isotopes Inc.'s principal executive offices?

The principal executive offices are located at 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, DC 20004.

What is the IRS Employer Identification Number (EIN) for ASP Isotopes Inc.?

The IRS Employer Identification Number for ASP Isotopes Inc. is 87-2618235.

What is the state of incorporation for ASP Isotopes Inc.?

ASP Isotopes Inc. is incorporated in Delaware.

Filing Stats: 540 words · 2 min read · ~2 pages · Grade level 9.9 · Accepted 2025-09-30 10:56:31

Key Financial Figures

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On September 30, 2025, ASP Isotopes Inc. (the "Company") issued a press release announcing a purchase order for enriched Barium-137 from a U.S.-based customer. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release, dated September 30, 2025, of ASP Isotopes Inc. announcing a purchase order for enriched Barium-137 from a U.S.-based customer. 104 Cover Page Interactive Date File (embedded within the Inline XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASP ISOTOPES INC. Date: September 30, 2025 By: /s/ Donald G. Ainscow Name: Donald G. Ainscow Title: Executive Vice President, General Counsel and Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing